Pediatric Radiology

, Volume 35, Issue 2, pp 103–115 | Cite as

Langerhans’ cell histiocytosis: pathology, imaging and treatment of skeletal involvement

  • E. Michel Azouz
  • Gaurav Saigal
  • Maria M. Rodriguez
  • Antonello Podda


Langerhans’ cell histiocytosis (LCH) is manifested in a variety of ways, the most common being the eosinophilic granuloma, a localized, often solitary bone lesion that occurs predominantly in the pediatric age group. The hallmark of LCH is the proliferation and accumulation of a specific histiocyte: the Langerhans’ cell. In bone this may cause pain and adjacent soft-tissue swelling, but some lesions are asymptomatic. LCH can involve any bone, but most lesions occur in the skull (especially the calvarium and temporal bones), the pelvis, spine, mandible, ribs, and tubular bones. Imaging diagnosis of the disease in bone is first based on the plain radiographic appearance, which is usually a central destructive, aggressive-looking lesion. In the skull, the lesions develop in the diploic space, are lytic, and their edges may be beveled, scalloped or confluent (geographic), or show a “button sequestrum.” Vertebral body involvement usually causes collapse, resulting in vertebra plana. With significant recent improvements in the quality of gamma cameras, imaging techniques, and in studying children, bone scintigraphy at diagnosis and on follow-up usually reveals the sites of active disease, especially when the involvement is polyostotic. CT and MR imaging are very useful in providing detailed cross-sectional anatomic detail of the involved bone, including the bone marrow and the adjacent soft tissues. CT is better suited for demonstrating bone detail and MR imaging for bone marrow and soft-tissue involvement.


Langerhans’ cell Histiocytosis Eosinophilic granuloma Pediatric Pathology Imaging 


  1. 1.
    Egeler RM, D’Angio GJ (1995) Langerhans cell histiocytosis. J Pediatr 127:1–11PubMedGoogle Scholar
  2. 2.
    Broadbent V, Egeler M, Nesbit ME (1994) Langerhans cell histiocytosis: clinical and epidemiological aspects. Br J Cancer 70:S11-S16Google Scholar
  3. 3.
    Favara BE, Feller AC, Pauli M (1997) Contemporary classification of histiocytic disorders. Med Pediatr Oncol 29:157–166CrossRefPubMedGoogle Scholar
  4. 4.
    Berry DH, Gresik MV, Humphrey GB, et al (1986) Natural history of histiocytosis X: a pediatric oncology group study. Med Pediatr Oncol 14:1–5PubMedGoogle Scholar
  5. 5.
    Meyer JS, Harty MP, Mahboubi S, et al (1995) Langerhans cell histiocytosis: presentation and evolution of radiologic findings with clinical correlation. Radiographics 15:1135–1146PubMedGoogle Scholar
  6. 6.
    Arico M, Clementi R, Caselli D, et al (2003) Histiocytic disorders. Hematol J 4:171–179CrossRefPubMedGoogle Scholar
  7. 7.
    Chu T, Jaffe R (1994) The normal Langerhans cell and the LCH cell. Br J Cancer 23:S4–S10Google Scholar
  8. 8.
    Stull MA, Kransdorf MJ, Devaney KO (1992) Langerhans cell histiocytosis of bone. Radiographics 12:801–823PubMedGoogle Scholar
  9. 9.
    Webb DKH (1999) Histiocytic syndromes. In: Lilleyman J, Hann I, Blanchette V (eds) Pediatric hematology, 2nd edn. Churchill Livingstone, London, pp 356–361Google Scholar
  10. 10.
    Willman CL (1994) Detection of clonal histiocytes in Langerhans cell histiocytosis: biology and clinical significance. Br J Cancer 23:S29–S33Google Scholar
  11. 11.
    Hutchison RE, Uner AH (1996) Pediatric neoplasia. Morphology and biology. In: Parham DM (ed) Tumors of the lymphoid organs. Lippincott-Raven, Philadelphia, pp 519–521Google Scholar
  12. 12.
    Fernandez-Latorre F, Menor-Serrano F, Alonso-Charterina S, et al (2000) Langerhans cell histiocytosis of the temporal bone in pediatric patients: imaging and follow-up. AJR 174:217–221PubMedGoogle Scholar
  13. 13.
    Ugarriza FL, Cabezudo JM, Porras LF, et al (2003) Solitary eosinophilic granuloma of the cervicothoracic junction causing neurological deficit. Br J Neurosurg 17:178–181PubMedGoogle Scholar
  14. 14.
    Puertas EB, Milani C, Chagas JC, et al (2003) Surgical treatment of eosinophilic granuloma in the thoracic spine in patients with neurological lesions. J Pediatr Orthop B 12:303–306CrossRefPubMedGoogle Scholar
  15. 15.
    Kozlowski K, Grigor WG (1980) Probably congenital histiocytosis X with unusual radiographic finding in a 7-week-old infant. Pediatr Radiol 9:45–47PubMedGoogle Scholar
  16. 16.
    Seibert DJ (1994) Eosinophilic granuloma. Pediatric case of the day. AJR 162:1473–1474PubMedGoogle Scholar
  17. 17.
    Bollini G, Jouve JL, Gentet JC, et al (1991) Bone lesions in histiocytosis X. J Pediatr Orthop 11:469–477PubMedGoogle Scholar
  18. 18.
    Gardner DJ, Azouz EM (1988) Solitary lucent epiphyseal lesions in children. Skeletal Radiol 17:497–504PubMedGoogle Scholar
  19. 19.
    Usui M, Matsuno T, Kobayashi M, et al (1983) Eosinophilic granuloma of the growing epiphysis. Clin Orthop 176:201–205PubMedGoogle Scholar
  20. 20.
    Leeson MC, Smith A, Carter JR, et al (1985) Eosinophilic granuloma of bone in the growing epiphysis. J Pediatr Orthop 5:147–150PubMedGoogle Scholar
  21. 21.
    Hung PC, Wang HS, Jaing TH, et al (2003) From normal to abnormal MR findings within three weeks in a solitary pelvic Langerhans histiocytosis. Skeletal Radiol 32:481–484CrossRefPubMedGoogle Scholar
  22. 22.
    Sartoris DJ, Parker BR (1984) Histiocytosis X: rate and pattern of resolution of osseous lesions. Radiology 152:679–684PubMedGoogle Scholar
  23. 23.
    Derbekyan V, Azouz EM (1984) Radiological case of the month: solitary costal eosinophilic granuloma. Am J Dis Child 138:885–886Google Scholar
  24. 24.
    Jabra AA, Fishman EK (1992) Eosinophilic granuloma simulating an aggressive rib neoplasm: CT evaluation. Pediatr Radiol 22:447–448PubMedGoogle Scholar
  25. 25.
    Mitnick JS, Pinto RS (1980) Computed tomography in the diagnosis of eosinophilic granuloma. J Comput Assist Tomogr 4:791–793PubMedGoogle Scholar
  26. 26.
    Tordeur M, Wybier M, Laporte JL, et al (2000) Button sequestrum in a case of localized Langerhans cell histiocytosis of the ilium: case report. Can Assoc Radiol J 51:90–92PubMedGoogle Scholar
  27. 27.
    Van Nieuwenhuyse JP, Clapuyt P, Malghem J, et al (1996) Radiographic skeletal survey and radionuclide bone scan in Langerhans cell histiocytosis of bone. Pediatr Radiol 26:734–738PubMedGoogle Scholar
  28. 28.
    Schaub T, Eissner D, Hahn K, et al (1983) Bone scanning in the detection and follow-up of skeletal lesions in histiocytosis X. Ann Radiol 26:407–410PubMedGoogle Scholar
  29. 29.
    Crone-Münzebrock W, Brassow F (1983) A comparison of radiographic and bone scan findings in histiocytosis X. Skeletal Radiol 9:170–173PubMedGoogle Scholar
  30. 30.
    Conway JJ (1996) Commentary. Pediatr Radiol 26:742–743PubMedGoogle Scholar
  31. 31.
    Shenouda NF, Azouz EM (1991) Case report 702: Langerhans cell histiocytosis of the skin, skull, and mandible with calcification in associated soft tissue masses. Skeletal Radiol 20:620–623PubMedGoogle Scholar
  32. 32.
    Geusens E, Brys P, Ghekiere J, et al (1998) Langerhans cell histiocytosis of the cervical spine: case report of an unusual location. Eur Radiol 8:1142–1144CrossRefPubMedGoogle Scholar
  33. 33.
    Woertler K (2003) Benign bone tumors and tumor-like lesions: value of cross-sectional imaging. Eur Radiol 13:1820–1835CrossRefPubMedGoogle Scholar
  34. 34.
    George JC, Buckwalter KA, Cohen MD, et al (1994) Langerhans cell histiocytosis of bone: MR imaging. Pediatr Radiol 24:29–32PubMedGoogle Scholar
  35. 35.
    Binkovitz LA, Olshefski RS, Adler BH (2003) Coincidence FDG-PET in the evaluation of Langerhans cell histiocytosis: preliminary findings. Pediatr Radiol 33:598–602CrossRefPubMedGoogle Scholar
  36. 36.
    Schmidt S, Eich G, Hanquinet S, et al (2004) Extra-osseous involvement of Langerhans cell histiocytosis in children. Pediatr Radiol 34:313–321CrossRefPubMedGoogle Scholar
  37. 37.
    Hindman BW, Thomas RD, Young LW, et al (1998) Langerhans cell histiocytosis: unusual skeletal manifestations observed in thirty-four cases. Skeletal Radiol 27:177–181CrossRefPubMedGoogle Scholar
  38. 38.
    Taranath A, Onikul E (2004) Fluid-fluid levels in transcalvarial Langerhans cell histiocytosis. Pediatr Radiol 34:363CrossRefPubMedGoogle Scholar
  39. 39.
    Oliveira M, Steinbok P, Wu J, et al (2003) Spontaneous resolution of calvarial eosinophilic granuloma in children. Pediatr Neurosurg 38:247–252CrossRefPubMedGoogle Scholar
  40. 40.
    Muscolo DL, Slullitel G, Ranalletta M, et al (2003) Spontaneous remission of massive solitary eosinophilic granuloma of the femur. J Pediatr Orthop 23:763–765CrossRefPubMedGoogle Scholar
  41. 41.
    Key SJ, O’Brien CJ, Silvester KC, et al (2004) Eosinophilic granuloma: resolution of maxillofacial bony lesions following minimal intervention. Report of three cases and a review of the literature. J Craniomaxillofac Surg 32:170–175CrossRefPubMedGoogle Scholar
  42. 42.
    Cohen M, Zornoza J, Cangir A, et al (1980) Direct injection of methylprednisolone sodium succinate in the treatment of solitary eosinophilic granuloma of bone: a report of 9 cases. Radiology 136:289–293PubMedGoogle Scholar
  43. 43.
    Harris GJ, Woo KI (2003) Eosinophilic granuloma of the orbit: a paradox of aggressive destruction responsive to minimal intervention. Trans Am Ophthalmol Soc 101:93–103PubMedGoogle Scholar
  44. 44.
    Libicher M, Roeren TH, Tröger J (1995) Localized Langerhans cell histiocytosis of bone: treatment and follow-up in children. Pediatr Radiol 25:S134–S137PubMedGoogle Scholar
  45. 45.
    Gadner H, Heitger A, Grois N, et al (1994) DAL HX 83 study group. Treatment strategy for disseminated Langerhans cell histiocytosis. Med Ped Oncol 23:72–80Google Scholar
  46. 46.
    Gadner H, Grois N, Arico M, et al (2001) Histiocyte society: a randomized trial of treatment for multisystem Langerhans cell histiocytosis. J Pediatr 138:728–734. Erratum in: J Pediatr 139:170CrossRefPubMedGoogle Scholar
  47. 47.
    Mahmoud HH, Wang WC, Murphy SB (1991) Cyclosporine therapy for advanced Langerhans cell histiocytosis. Blood 77:721–725PubMedGoogle Scholar
  48. 48.
    Kelly KM, Pritchard J (1994) Monoclonal antibody therapy in Langerhans cell histiocytosis—feasible and reasonable? Br J Cancer 23:S54–S55Google Scholar
  49. 49.
    Jakobson AM, Kreuger A, Hagberg H, et al (1987) Treatment of Langerhans cell histiocytosis with alpha-interferon. Lancet 2:1520–1521CrossRefGoogle Scholar
  50. 50.
    Bellmunt J, Albanell J, Salud A, et al (1992) Interferon and disseminated Langerhans cell histiocytosis. Med Pediatr Oncol 20:336–337PubMedGoogle Scholar
  51. 51.
    Saven A, Burian C (1999) Cladribine activity in adult Langerhans-cell histiocytosis. Blood 93:4125–4130PubMedGoogle Scholar
  52. 52.
    Stine KC, Saylors RL, Williams LL, et al (1997) 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients. Med Pediatr Oncol 29:288–292CrossRefPubMedGoogle Scholar
  53. 53.
    Thomas L, Ducros B, Secchi T, et al (1993) Successful treatment of adult’s Langerhans cell histiocytosis with thalidomide: report of two cases and literature review. Arch Dermatol 129:1261–1264CrossRefPubMedGoogle Scholar
  54. 54.
    Henter JI, Karlen J, Calming U, et al (2001) Successful treatment of Langerhans cell histiocytosis with etanercept. N Engl J Med 345:1577–1578CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • E. Michel Azouz
    • 1
  • Gaurav Saigal
    • 2
  • Maria M. Rodriguez
    • 3
  • Antonello Podda
    • 4
  1. 1.Pediatric Radiology Section, Department of RadiologyUniversity of MiamiMiamiUSA
  2. 2.Department of Medical ImagingMcGill UniversityQuebecCanada
  3. 3.Department of PathologyUniversity of MiamiMiamiUSA
  4. 4.Division of Pediatric Hematology/OncologyUniversity of MiamiMiamiUSA

Personalised recommendations